ZA200001586B - Processes and intermediates for preparing anti-cancer compounds. - Google Patents

Processes and intermediates for preparing anti-cancer compounds.

Info

Publication number: ZA200001586B
Authority: ZA; South Africa
Prior art keywords: intermediates; processes; preparing anti; cancer compounds; cancer
Prior art date: 1999-03-31

Application number

ZA200001586A

Other languages

English (en)

Inventor

Richard Shelton Lehner

Timothy Norris

Dinos Paul Santafianos

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-31

Filing date

2000-03-29

Publication date

2001-10-01

2000-03-29 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-10-01 Publication of ZA200001586B publication Critical patent/ZA200001586B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
- C22B15/00—Obtaining copper
- C22B15/0002—Preliminary treatment
- C22B15/0004—Preliminary treatment without modification of the copper constituent
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
- C22B15/00—Obtaining copper
- C22B15/0063—Hydrometallurgy
- C22B15/0065—Leaching or slurrying
- C22B15/0067—Leaching or slurrying with acids or salts thereof
- C22B15/0071—Leaching or slurrying with acids or salts thereof containing sulfur
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P10/00—Technologies related to metal processing
- Y02P10/20—Recycling

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Metallurgy (AREA)
Mechanical Engineering (AREA)
Materials Engineering (AREA)
Manufacturing & Machinery (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

ZA200001586A 1999-03-31 2000-03-29 Processes and intermediates for preparing anti-cancer compounds. ZA200001586B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12707299P	1999-03-31	1999-03-31

Publications (1)

Publication Number	Publication Date
ZA200001586B true ZA200001586B (en)	2001-10-01

Family

ID=22428179

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200001586A ZA200001586B (en)	1999-03-31	2000-03-29	Processes and intermediates for preparing anti-cancer compounds.

Country Status (49)

Country	Link
US (1)	US6476040B1 (is)
EP (1)	EP1044969B1 (is)
JP (2)	JP3420549B2 (is)
KR (2)	KR100430210B1 (is)
CN (2)	CN100351242C (is)
AP (2)	AP1655A (is)
AR (1)	AR018705A1 (is)
AT (1)	ATE348098T1 (is)
AU (2)	AU781402B2 (is)
BG (1)	BG65194B1 (is)
BR (1)	BRPI0001486B8 (is)
CA (2)	CA2427221C (is)
CO (1)	CO5160273A1 (is)
CR (1)	CR6165A (is)
CZ (1)	CZ299426B6 (is)
DE (1)	DE60032275T2 (is)
DK (1)	DK1044969T3 (is)
DZ (1)	DZ3030A1 (is)
EA (3)	EA004654B1 (is)
EE (1)	EE04589B1 (is)
EG (1)	EG22506A (is)
ES (1)	ES2278578T3 (is)
GE (1)	GEP20022653B (is)
GT (1)	GT200000037A (is)
HR (1)	HRP20000182B1 (is)
HU (1)	HU227698B1 (is)
ID (1)	ID25427A (is)
IL (2)	IL168036A (is)
IS (1)	IS2468B (is)
MA (1)	MA25087A1 (is)
MY (1)	MY136270A (is)
NO (2)	NO321952B1 (is)
NZ (2)	NZ512818A (is)
OA (1)	OA11335A (is)
PA (1)	PA8491901A1 (is)
PE (1)	PE20001599A1 (is)
PL (1)	PL339330A1 (is)
PT (1)	PT1044969E (is)
RS (1)	RS49836B (is)
SG (2)	SG121687A1 (is)
SK (1)	SK287339B6 (is)
SV (1)	SV2002000047A (is)
TN (1)	TNSN00064A1 (is)
TR (1)	TR200000837A2 (is)
TW (1)	TW553939B (is)
UA (2)	UA70928C2 (is)
UY (1)	UY26086A1 (is)
YU (1)	YU13200A (is)
ZA (1)	ZA200001586B (is)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6706721B1 (en)	1998-04-29	2004-03-16	Osi Pharmaceuticals, Inc.	N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US7087613B2 (en)	1999-11-11	2006-08-08	Osi Pharmaceuticals, Inc.	Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA74803C2 (uk) *	1999-11-11	2006-02-15	Осі Фармасьютікалз, Інк.	Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
EP1415987B1 (en)	2000-10-20	2007-02-28	Eisai R&D Management Co., Ltd.	Nitrogenous aromatic ring compounds as anti cancer agents
US7132427B2 (en)	2001-06-21	2006-11-07	Ariad Pharmaceuticals, Inc.	Quinazolines and uses thereof
US7078409B2 (en)	2002-03-28	2006-07-18	Beta Pharma, Inc.	Fused quinazoline derivatives useful as tyrosine kinase inhibitors
EP1521747B1 (en)	2002-07-15	2018-09-05	Symphony Evolution, Inc.	Receptor-type kinase modulators and methods of use
US7148231B2 (en) *	2003-02-17	2006-12-12	Hoffmann-La Roche Inc.	[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
EP1604665B1 (en)	2003-03-10	2011-05-11	Eisai R&D Management Co., Ltd.	C-kit kinase inhibitor
US7618975B2 (en)	2003-07-03	2009-11-17	Myriad Pharmaceuticals, Inc.	4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US8309562B2 (en) *	2003-07-03	2012-11-13	Myrexis, Inc.	Compounds and therapeutical use thereof
HRP20080329T3 (en)	2003-09-16	2008-08-31	Astrazeneca Ab	Quinazoline derivatives as tyrosine kinase inhibitors
SI2392564T1 (sl)	2003-09-26	2014-02-28	Exelixis, Inc.	c-Met modulatorji in postopki uporabe
EP1683785B1 (en)	2003-11-11	2013-10-16	Eisai R&D Management Co., Ltd.	Urea derivative and process for producing the same
MXPA06012756A (es) *	2004-05-06	2007-01-16	Warner Lambert Co	4-fenilamino-quinazolin-6-il-amidas.
DE602005013990D1 (de)	2004-09-17	2009-05-28	Eisai R&D Man Co Ltd	Medizinische zusammensetzung mit verbesserter stabilität und reduzierten gelierungseigenschaften
US8258145B2 (en)	2005-01-03	2012-09-04	Myrexis, Inc.	Method of treating brain cancer
CA2592900A1 (en)	2005-01-03	2006-07-13	Myriad Genetics Inc.	Nitrogen containing bicyclic compounds and therapeutical use thereof
US7625911B2 (en) *	2005-01-12	2009-12-01	Mai De Ltd.	Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
WO2006090930A1 (ja)	2005-02-28	2006-08-31	Eisai R & D Management Co., Ltd.	スルホンアミド化合物の新規併用
US20100105031A1 (en) *	2005-08-01	2010-04-29	Esai R & D Management Co., Ltd.	Method for prediction of the efficacy of vascularization inhibitor
JP4989476B2 (ja)	2005-08-02	2012-08-01	エーザイ・アール・アンド・ディー・マネジメント株式会社	血管新生阻害物質の効果を検定する方法
US20090053236A1 (en)	2005-11-07	2009-02-26	Eisai R & D Management Co., Ltd.	USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR
WO2007061130A1 (ja) *	2005-11-22	2007-05-31	Eisai R & D Management Co., Ltd.	多発性骨髄腫に対する抗腫瘍剤
AU2007252506C1 (en) *	2006-05-18	2012-07-19	Eisai R & D Management Co., Ltd.	Antitumor agent for thyroid cancer
WO2008001956A1 (en) *	2006-06-29	2008-01-03	Eisai R & D Management Co., Ltd.	Therapeutic agent for liver fibrosis
CN101547910A (zh)	2006-07-28	2009-09-30	合成纤维有限公司	结晶埃罗替尼
EP2065372B1 (en)	2006-08-28	2012-11-28	Eisai R&D Management Co., Ltd.	Antitumor agent for undifferentiated gastric cancer
US8372856B2 (en) *	2006-10-27	2013-02-12	Synthon Bv	Hydrates of erlotinib hydrochloride
WO2008088088A1 (ja)	2007-01-19	2008-07-24	Eisai R & D Management Co., Ltd.	膵癌治療用組成物
CA2676796C (en)	2007-01-29	2016-02-23	Eisai R & D Management Co., Ltd.	Composition for treatment of undifferentiated gastric cancer
PT2170844T (pt) *	2007-02-21	2016-08-05	Natco Pharma Ltd	Novos polimorfos de cloridrato de erlotinib e método de preparação
KR101441930B1 (ko)	2007-04-04	2014-09-19	시플라 리미티드	에르로티닙 및 그의 약학적으로 허용가능한 염의 제조방법
US20090012295A1 (en) *	2007-06-25	2009-01-08	Ales Gavenda	Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of Erlotinib
WO2009007984A2 (en)	2007-07-11	2009-01-15	Hetero Drugs Limited	An improved process for erlotinib hydrochloride
US20090124642A1 (en) *	2007-08-23	2009-05-14	Augusto Canavesi	Crystalline forms of Erlotinib HCI and formulations thereof
US20090131665A1 (en) *	2007-08-23	2009-05-21	Ales Gavenda	Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI
US20090076042A1 (en) *	2007-09-15	2009-03-19	Protia, Llc	Deuterium-enriched erlotinib
KR101513326B1 (ko)	2007-11-09	2015-04-17	에자이 알앤드디 매니지먼트 가부시키가이샤	혈관 신생 저해 물질과 항종양성 백금 착물의 병용
EP2248804A4 (en) *	2008-01-29	2014-09-10	Eisai R&D Man Co Ltd	COMBINED USE OF AN ANGIOGENESIS INHIBITOR AND A TAXANE
WO2009121042A1 (en) *	2008-03-28	2009-10-01	Concert Pharmaceuticals, Inc.	Quinazoline derivatives and methods of treatment
EP2307386A1 (en) *	2008-07-07	2011-04-13	Plus Chemicals S.A.	Crystalline forms of erlotinib base and erlotinib hcl
KR101132937B1 (ko)	2008-10-01	2012-04-06	주식회사종근당	Ｎ-(3-에티닐페닐)-6,7-비스(2-메톡시에톡시)-4-퀴나졸린아민 납실레이트 염
WO2010040212A1 (en) *	2008-10-08	2010-04-15	Apotex Pharmachem Inc.	Processes for the preparation of erlotinib hydrochloride
MX2011007620A (es)	2009-01-16	2011-11-04	Exelixis Inc	Sal de malato de n(4-{[6,7-bis(metiloxi)quinolin-4-il]oxi}fenil)-n '-(4-fluorofenil) ciclopropano-1,1-dicarboxamida, y sus formas cristalinas para el tratamiento de cancer.
US8440823B2 (en)	2009-03-26	2013-05-14	Ranbaxy Laboratories Limited	Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
AU2010285740C1 (en)	2009-08-19	2016-03-17	Eisai R&D Management Co., Ltd.	Quinoline derivative-containing pharmaceutical composition
EP2499118A2 (en)	2009-11-12	2012-09-19	Ranbaxy Laboratories Limited	Processes for the preparation of erlotinib hydrochloride form a and erlotinib hydrochloride form b
WO2011068404A2 (en)	2009-12-02	2011-06-09	Ultimorphix Technologies B.V.	Administration of n-(3-ethynylphenylamino)-6,7-bis(2- methoxyethoxy)-4-quinazolinamine mesylate salt by inhalation
MX2012014776A (es)	2010-06-25	2013-01-29	Eisai R&D Man Co Ltd	Agente antitumoral que emplea compuestos con efecto inhibidor de cinasas combinados.
NZ628796A (en)	2010-07-23	2016-02-26	Generics Uk Ltd	Pure erlotinib
IT1402029B1 (it)	2010-10-14	2013-08-28	Italiana Sint Spa	Procedimento per la preparazione di erlotinib
BR112013021941B1 (pt)	2011-04-18	2022-11-16	Eisai R & D Management Co., Ltd	Agente terapêutico para tumor
EP3444363B1 (en)	2011-06-03	2020-11-25	Eisai R&D Management Co., Ltd.	Biomarkers for prediciting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
CN102267952B (zh) *	2011-06-21	2013-12-11	天津市汉康医药生物技术有限公司	喹唑啉类化合物、其制备方法和用途
CN103420924B (zh) *	2012-05-25	2016-08-31	浙江九洲药业股份有限公司	一种盐酸埃罗替尼晶型a的制备方法
WO2014037961A1 (en)	2012-09-04	2014-03-13	Shilpa Medicare Limited	Crystalline erlotinib hydrochloride process
WO2014098176A1 (ja)	2012-12-21	2014-06-26	エーザイ・アール・アンド・ディー・マネジメント株式会社	キノリン誘導体のアモルファス及びその製造方法
WO2014118737A1 (en)	2013-01-31	2014-08-07	Ranbaxy Laboratories Limited	Erlotinib salts
CN105264380B (zh)	2013-05-14	2017-09-05	卫材R&D管理有限公司	用于预测和评价子宫内膜癌受试者对乐伐替尼化合物响应性的生物标志
CN103333124B (zh) *	2013-05-28	2015-03-25	埃斯特维华义制药有限公司	一种制备盐酸厄洛替尼晶型f的方法
MX394386B (es)	2014-08-28	2025-03-24	Eisai R&D Man Co Ltd	Derivado de quinolina muy puro y metodo para su produccion.
CA2908441A1 (en)	2014-10-28	2016-04-28	Cerbios-Pharma Sa	Process for the preparation of erlotinib
MX385403B (es)	2015-02-25	2025-03-18	Eisai R&D Man Co Ltd	Método para suprimir el amargor de un derivado de quinoleína.
KR20250020678A (ko)	2015-03-04	2025-02-11	머크 샤프 앤드 돔 엘엘씨	암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
SG11201710198YA (en)	2015-06-16	2018-01-30	Eisai R&D Man Co Ltd	Anticancer agent
WO2017030161A1 (ja)	2015-08-20	2017-02-23	エーザイ・アール・アンド・ディー・マネジメント株式会社	腫瘍治療剤
CN105884653A (zh) *	2016-06-08	2016-08-24	浙江汇能生物股份有限公司	一种埃罗替尼衍生物及其制备方法
CN106279585A (zh) *	2016-08-26	2017-01-04	宁波圣达精工智能科技有限公司	一种阻燃智能密集书架的制备方法
EP3581183B1 (en)	2017-02-08	2023-11-29	Eisai R&D Management Co., Ltd.	Tumor-treating pharmaceutical composition
CN110831597A (zh)	2017-05-16	2020-02-21	卫材R&D管理有限公司	肝细胞癌的治疗

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4747498A (en) *	1986-06-27	1988-05-31	Sunbeam Plastics Corporation	Safety dispensing closure-container package
GB9300059D0 (en)	1992-01-20	1993-03-03	Zeneca Ltd	Quinazoline derivatives
JP2657760B2 (ja) *	1992-07-15	1997-09-24	小野薬品工業株式会社	４−アミノキナゾリン誘導体およびそれを含有する医薬品
EP0817775B1 (en) *	1995-03-30	2001-09-12	Pfizer Inc.	Quinazoline derivatives
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines
CN1125817C (zh)	1996-02-13	2003-10-29	曾尼卡有限公司	作为vegf抑制剂的喹唑啉衍生物
JP4464466B2 (ja)	1996-03-05	2010-05-19	アストラゼネカ・ユーケイ・リミテッド	４―アニリノキナゾリン誘導体
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
US6225499B1 (en)	1997-07-14	2001-05-01	Catalytica Pharmaceuticals, Inc.	Process for preparing aminoarylacetylenes
MEP42008A (en)	1998-04-29	2011-02-10	Osi Farmaceuticals Inc	N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate

2000
- 2000-03-03 YU YU13200A patent/YU13200A/sh unknown
- 2000-03-03 RS YUP-132/00A patent/RS49836B/sr unknown
- 2000-03-10 OA OA1200000071A patent/OA11335A/en unknown
- 2000-03-14 CR CR6165A patent/CR6165A/es unknown
- 2000-03-17 PA PA20008491901A patent/PA8491901A1/es unknown
- 2000-03-20 ES ES00302256T patent/ES2278578T3/es not_active Expired - Lifetime
- 2000-03-20 DK DK00302256T patent/DK1044969T3/da active
- 2000-03-20 EP EP00302256A patent/EP1044969B1/en not_active Expired - Lifetime
- 2000-03-20 AT AT00302256T patent/ATE348098T1/de not_active IP Right Cessation
- 2000-03-20 DE DE60032275T patent/DE60032275T2/de not_active Expired - Lifetime
- 2000-03-20 PT PT00302256T patent/PT1044969E/pt unknown
- 2000-03-21 IS IS5411A patent/IS2468B/is unknown
- 2000-03-22 CO CO00020444A patent/CO5160273A1/es unknown
- 2000-03-23 IL IL168036A patent/IL168036A/en not_active IP Right Cessation
- 2000-03-23 IL IL13524500A patent/IL135245A0/xx not_active IP Right Cessation
- 2000-03-27 UA UA2000031727A patent/UA70928C2/uk unknown
- 2000-03-27 BR BRPI0001486A patent/BRPI0001486B8/pt not_active IP Right Cessation
- 2000-03-27 UA UA20040503766A patent/UA80955C2/uk unknown
- 2000-03-27 EG EG20000364A patent/EG22506A/xx active
- 2000-03-27 SG SG200001746A patent/SG121687A1/en unknown
- 2000-03-27 SK SK444-2000A patent/SK287339B6/sk not_active IP Right Cessation
- 2000-03-27 ID IDP20000240A patent/ID25427A/id unknown
- 2000-03-27 SG SG200302185A patent/SG115536A1/en unknown
- 2000-03-27 TW TW089105605A patent/TW553939B/zh not_active IP Right Cessation
- 2000-03-28 BG BG104278A patent/BG65194B1/bg unknown
- 2000-03-28 AU AU22620/00A patent/AU781402B2/en not_active Expired
- 2000-03-29 DZ DZ000059A patent/DZ3030A1/xx active
- 2000-03-29 AP APAP/P/2003/002757D patent/AP1655A/en active
- 2000-03-29 MA MA25940A patent/MA25087A1/fr unknown
- 2000-03-29 JP JP2000091300A patent/JP3420549B2/ja not_active Expired - Lifetime
- 2000-03-29 AR ARP000101413A patent/AR018705A1/es active IP Right Grant
- 2000-03-29 UY UY26086A patent/UY26086A1/es not_active Application Discontinuation
- 2000-03-29 ZA ZA200001586A patent/ZA200001586B/xx unknown
- 2000-03-29 CA CA002427221A patent/CA2427221C/en not_active Expired - Lifetime
- 2000-03-29 CA CA002302965A patent/CA2302965C/en not_active Expired - Lifetime
- 2000-03-29 TN TNTNSN00064A patent/TNSN00064A1/fr unknown
- 2000-03-29 AP APAP/P/2000/001778A patent/AP1265A/en active
- 2000-03-29 MY MYPI20001252A patent/MY136270A/en unknown
- 2000-03-30 NZ NZ512818A patent/NZ512818A/xx not_active IP Right Cessation
- 2000-03-30 NZ NZ503683A patent/NZ503683A/en not_active IP Right Cessation
- 2000-03-30 US US09/538,635 patent/US6476040B1/en not_active Expired - Lifetime
- 2000-03-30 KR KR1020000016386A patent/KR100430210B1/ko not_active Expired - Lifetime
- 2000-03-30 NO NO20001648A patent/NO321952B1/no not_active IP Right Cessation
- 2000-03-30 HU HU0001353A patent/HU227698B1/hu unknown
- 2000-03-30 EA EA200000274A patent/EA004654B1/ru not_active IP Right Cessation
- 2000-03-30 TR TR2000/00837A patent/TR200000837A2/xx unknown
- 2000-03-30 GT GT200000037A patent/GT200000037A/es unknown
- 2000-03-30 EA EA200201244A patent/EA005561B1/ru not_active IP Right Cessation
- 2000-03-30 EE EEP200000255A patent/EE04589B1/xx not_active IP Right Cessation
- 2000-03-30 SV SV2000000047A patent/SV2002000047A/es not_active Application Discontinuation
- 2000-03-30 PL PL00339330A patent/PL339330A1/xx not_active Application Discontinuation
- 2000-03-30 EA EA200201245A patent/EA005892B1/ru not_active IP Right Cessation
- 2000-03-30 PE PE2000000277A patent/PE20001599A1/es not_active Application Discontinuation
- 2000-03-30 CZ CZ20001155A patent/CZ299426B6/cs not_active IP Right Cessation
- 2000-03-31 GE GEAP20005284A patent/GEP20022653B/en unknown
- 2000-03-31 HR HR20000182A patent/HRP20000182B1/xx not_active IP Right Cessation
- 2000-03-31 CN CNB2005100763600A patent/CN100351242C/zh not_active Expired - Lifetime
- 2000-03-31 CN CNB001045954A patent/CN1215061C/zh not_active Expired - Lifetime
2002
- 2002-07-29 KR KR10-2002-0044610A patent/KR100430209B1/ko not_active Expired - Lifetime
- 2002-12-12 JP JP2002360742A patent/JP4074509B2/ja not_active Expired - Lifetime
2005
- 2005-04-08 AU AU2005201494A patent/AU2005201494B2/en not_active Expired
- 2005-10-13 NO NO20054715A patent/NO324745B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN100351242C (zh)	2007-11-28
EG22506A (en)	2003-03-31
EP1044969A2 (en)	2000-10-18
DK1044969T3 (da)	2007-04-23
HUP0001353A2 (hu)	2001-05-28
NZ503683A (en)	2001-09-28
ATE348098T1 (de)	2007-01-15
NZ512818A (en)	2003-01-31
BRPI0001486B8 (pt)	2021-05-25
CN1215061C (zh)	2005-08-17
DZ3030A1 (fr)	2004-03-27
EA005892B1 (ru)	2005-06-30
IS2468B (is)	2008-12-15
MA25087A1 (fr)	2000-10-01
IS5411A (is)	2000-10-02
CZ299426B6 (cs)	2008-07-23
CA2302965A1 (en)	2000-09-30
JP2003176274A (ja)	2003-06-24
TW553939B (en)	2003-09-21
SK287339B6 (sk)	2010-07-07
AU2005201494A1 (en)	2005-05-05
NO20054715L (no)	2000-10-02
NO20001648L (no)	2000-10-02
US6476040B1 (en)	2002-11-05
CA2427221C (en)	2008-09-16
KR100430210B1 (ko)	2004-05-03
ID25427A (id)	2000-10-05
EA200201245A1 (ru)	2003-04-24
HUP0001353A3 (en)	2002-01-28
CO5160273A1 (es)	2002-05-30
GT200000037A (es)	2001-09-21
NO20001648D0 (no)	2000-03-30
SV2002000047A (es)	2002-01-23
PA8491901A1 (es)	2001-12-14
ES2278578T3 (es)	2007-08-16
EA004654B1 (ru)	2004-06-24
UY26086A1 (es)	2000-10-31
EA200000274A3 (ru)	2003-02-27
KR20020084903A (ko)	2002-11-13
SG115536A1 (en)	2005-10-28
HRP20000182A2 (en)	2001-04-30
JP4074509B2 (ja)	2008-04-09
AP1265A (en)	2004-03-26
EP1044969A3 (en)	2000-11-29
PE20001599A1 (es)	2001-01-18
KR100430209B1 (ko)	2004-05-03
BG104278A (en)	2001-08-31
IL135245A0 (en)	2001-05-20
HK1029790A1 (en)	2001-04-12
AR018705A1 (es)	2001-11-28
OA11335A (en)	2003-12-10
CZ20001155A3 (cs)	2001-03-14
TR200000837A2 (tr)	2000-11-21
SK4442000A3 (en)	2000-10-09
AP1655A (en)	2006-09-01
NO324745B1 (no)	2007-12-03
TNSN00064A1 (fr)	2005-11-10
CN1276370A (zh)	2000-12-13
UA80955C2 (en)	2007-11-26
NO321952B1 (no)	2006-07-24
BRPI0001486B1 (pt)	2019-01-29
YU13200A (sh)	2002-10-18
MY136270A (en)	2008-09-30
AU2005201494B2 (en)	2008-02-07
EE04589B1 (et)	2006-02-15
JP2000290262A (ja)	2000-10-17
KR20010014658A (ko)	2001-02-26
UA70928C2 (uk)	2004-11-15
SG121687A1 (en)	2006-05-26
CA2302965C (en)	2004-02-17
PT1044969E (pt)	2007-05-31
CR6165A (es)	2008-10-10
CA2427221A1 (en)	2000-09-30
HU0001353D0 (en)	2000-06-28
DE60032275D1 (de)	2007-01-25
GEP20022653B (en)	2002-03-25
RS49836B (sr)	2008-08-07
CN1699350A (zh)	2005-11-23
AU781402B2 (en)	2005-05-19
EA005561B1 (ru)	2005-04-28
JP3420549B2 (ja)	2003-06-23
BR0001486A (pt)	2001-05-02
EP1044969B1 (en)	2006-12-13
HRP20000182B1 (en)	2007-10-31
IL168036A (en)	2006-12-10
EA200201244A1 (ru)	2003-04-24
DE60032275T2 (de)	2007-07-12
AP2000001778A0 (en)	2000-03-31
AU2262000A (en)	2000-10-05
PL339330A1 (en)	2000-10-09
EA200000274A2 (ru)	2000-10-30
HU227698B1 (en)	2011-12-28
BG65194B1 (bg)	2007-06-29
EE200000255A (et)	2000-12-15

Publication	Publication Date	Title
ZA200001586B (en)	2001-10-01	Processes and intermediates for preparing anti-cancer compounds.
AP2003002757A0 (en)	2003-06-30	Process and intermediates for preparing anticancer compounds
MXPA01013362A (es)	2003-09-04	Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200200477B (en)	2003-06-25	2-pyrazolin-5-ones.
ZA200202537B (en)	2003-09-23	Pour-on-formulations.
ZA200203762B (en)	2004-01-28	4-pyridinyl-IN-acyl-L-phenylalanines.
ZA200108968B (en)	2003-09-05	New compounds.
MXPA01008188A (es)	2003-07-21	Procesos e intermediarios para la preparacion de 1,3-oxazin-6-onas y uracilos.
GB9922830D0 (en)	1999-11-24	Processes
HUP0200144A3 (en)	2003-03-28	Process for preparing pesticidal 5-amino-1-aryl-3 cyanopyrazole derivatives, and the new intermediates
HUP0200448A3 (en)	2005-01-28	Processes for preparing pesticidal intermediates
MXPA02000261A (es)	2003-08-20	Aminoindanos novedosos.
GB9924855D0 (en)	1999-12-22	Novel processes
HUP0102096A3 (en)	2002-08-28	Processes for preparing 1-cyclopropyl-5-phenyl-pentane-2,4-dion derivatives and their intermediates, and the new intermediates
IL146054A0 (en)	2002-07-25	Processes for preparing pesticidal intermediates
ZA200204581B (en)	2003-08-27	Nitro-sulfobenzamides.
ZA982850B (en)	1999-10-04	Processes and intermediates for preparing 2-fluorothiophene derivatives.
EP1242378A4 (en)	2003-01-15	NEW PROCEDURES
HUP0204521A3 (en)	2005-03-29	Vitamin d precursors, process for their preparation and their intermediates
ZA200002987B (en)	2001-12-14	Novel processes and intermediates.
ZA200001460B (en)	2000-10-24	Support.
ZA200110275B (en)	2003-05-28	Process for the preparation of intermediate compounds of drugs.
TW382910U (en)	2000-02-21	Structural improvement for the physique of the clog
ZA200203987B (en)	2004-01-28	Novel compounds.
ZA200110488B (en)	2003-03-20	New compounds.